Arif Janmohamed

Director Arif Janmohamed sold 475,869 shares for $9,098,183.58 across 3 transactions on NAVN

Arif Janmohamed, Director of Navan Inc., executed 3 separate sales totaling 475,869 shares for $9,098,183.58 between June 16–17, 2026, at a blended average price of $19.12. His post-transaction holdings of 2,280,989 shares represent a 17.3% reduction from his pre-transaction holdings of 2,756,858 shares. The company reported a net income of $-225,389,000.00 (negative) over its most recent full fiscal year, despite generating revenue of $194,934,000.00 and posting annual revenue growth of +30.8%. The stock currently trades at $21.91, representing -10.6% from its 52-week high of $24.50 and follows a 90-day surge of +147.0%.

Director Arif Janmohamed sold 1,650,000 shares (1.65M) for $15,099,627.13 at blended $9.15; retains 2,690,640 derivative shares.

Director Arif Janmohamed executed 2 separate sales totaling 1,650,000 shares for $15,099,627.13, offloading his entire non-derivative common-stock position. The sales occurred at $9.19 on 2026-06-12 and $9.00 on 2026-06-15 (blended average $9.15), at a time when the stock trades at $8.95 and sits -68.0% from its 52-week high of $27.99 and -20.2% below its 30-day average. The company remains unprofitable (net income $-116,496,000.00 in latest quarter) despite robust top-line growth of +31.7% annually, signaling a revenue expansion story not yet reflected in earnings power. The director retains 2,690,640 derivative shares through Lightspeed Opportunity Fund, L.P., indicating material ongoing economic exposure to NTSK despite the direct-equity sale.

Director Arif Janmohamed sold 2,024,131 shares (42.3% of holdings) for $40.9M at Navan, reducing stake to 2.76M shares.

Arif Janmohamed executed 5 separate sales on 2026-06-12 and 2026-06-15, divesting 2,024,131 shares for a blended average price of $20.19 and total proceeds of $40,862,524.89. This represents a material reduction of 42.3% of his pre-transaction holdings (from 4,780,989 to 2,756,858 shares), occurring while the company is unprofitable (net income of -$225,389,000.00 in the latest full fiscal year) despite posting annual revenue growth of +30.8%. The stock has recovered significantly from its 52-week low ($8.10), trading at $20.10 currently and up 118.5% over 90 days, though it remains 18.0% below the 52-week high ($24.50). The magnitude of this liquidation—removing a substantial portion of the director's equity stake at elevated prices—warrants examination of the rationale and any broader strategic implications at the company.